Home › Depression › California › Santa Monica
Depression clinical trials in Santa Monica, CA
4 studies for Depression are looking for participants at sites in and around Santa Monica (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RecruitingPhase 3
- Psychedelic Science Institute, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi away
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RecruitingPhase 2
- TRIP Clinical at Psychedelic Science Institute, Santa Monica
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RecruitingPhase 2
- UCLA, Westwood, Los Angeles · 4 mi away
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA52 studies
- New York City, NY45 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- Chicago, IL24 studies
- Pittsburgh, PA22 studies
- San Diego, CA21 studies
- Charleston, SC19 studies
- Houston, TX18 studies
- Orlando, FL17 studies
- Los Angeles, CA17 studies
- Miami, FL16 studies
Other studies in Santa Monica
- Non-Small Cell Lung Cancer45 studies
- Breast Cancer27 studies
- Colorectal Cancer23 studies
- Cancer (all types)21 studies
- Metastatic Cancer19 studies
- Lung Cancer15 studies
- Prostate Cancer15 studies
- Ovarian Cancer15 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure11 studies
- Endometrial Cancer10 studies
- Stomach Cancer9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.